Welcome to our dedicated page for Corecivic news (Ticker: CXW), a resource for investors and traders seeking the latest updates and insights on Corecivic stock.
CoreCivic, Inc. reports developments in government corrections, detention, residential reentry and real estate services. The company owns and operates partnership correctional, detention and residential reentry facilities in the United States, manages facilities for government agencies, and leases properties through its Properties segment. Recurring updates cover facility activations and occupancy, contract-related operations with federal and state customers, earnings guidance, and capital allocation.
Company news also includes credit facility changes, share repurchase authorization, executive responsibility for corrections and reentry operations, and complementary acquisitions such as Clinical Solutions Pharmacy, a mail-order pharmacy provider to correctional facilities.
CoreCivic (NYSE: CXW) has received a termination notice from U.S. Immigration and Customs Enforcement (ICE) for the South Texas Family Residential Center, effective August 9, 2024. The facility generated $156.6 million in 2023 and $39.3 million in Q1 2024. CoreCivic estimates an annualized earnings per share reduction of $0.38 to $0.41 due to the closure.
The facility, initially opened in the Obama-Biden administration, shifted its focus to detain single adults in 2021. Currently housing 1,561 individuals, CoreCivic leases the facility and land from a third-party lessor, with lease terms extending through September 2026. The company has suspended its financial guidance for 2024 due to cost uncertainties related to the closure.
CoreCivic, Inc. (NYSE: CXW) reported strong first quarter 2024 financial results with a 9% revenue increase year-over-year, significant share buybacks, and debt refinancing. The company achieved its target leverage range for the first time since 2020. Revenue increased across Federal, State, and Local segments. Adjusted net income improved to $27.9 million, or $0.25 per diluted share, compared to the same quarter in 2023. Despite the lease expiration at the Oklahoma Department of Corrections facility, positive results were driven by higher populations and lower expenses. Revenue from ICE increased compared to the previous year. Adjusted EBITDA rose to $89.5 million. Normalized FFO per share increased by 35% to $0.46. The company undertook significant share repurchases and successfully issued $500 million in senior unsecured notes, extending the term of existing debt by three years. The lease expiration at the California City Correctional Center is expected to impact per share results in the second quarter and full year 2024. Updated full year 2024 guidance includes net income of $52.7 million to $63.7 million, adjusted net income of $74.0 million to $85.0 million, and adjusted diluted EPS of $0.66 to $0.76.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.